NCT00631319View on ClinicalTrials.gov

A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

June 30, 2009

Conditions
Chronic Pain
Interventions
DRUG

OROS hydromorphone

hydromorphone 12, 16, 24, 32, 40, 48, or 64 mg tablets

DRUG

Placebo

Placebo

Sponsors

Lead Sponsor

Mallinckrodt
All Listed Sponsors
lead

Mallinckrodt

INDUSTRY

NCT00631319 - A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain | Biotech Hunter | Biotech Hunter